MET and liver cancer: This suggests that the loss of c-Met/HGF signaling, accompanied by a loss of antioxidants such as superoxide dismutase (SOD1) and NRF2, and its down regulation led to enhancement of liver tumor growth in the c-myc model of liver cancer by promoting a more favorable environment for cancerous growth.